반응식
F[C@@H:2]1[CH2:6][N:5]([C:7](OC(C)(C)C)=O)[C@H:4]([C:14](=[O:24])[NH:15][C@@H:16]2[C@@H:23]3[C@@H:19]([CH2:20][NH:21][CH2:22]3)[CH2:18][CH2:17]2)[CH2:3]1.Br[C:26]1[N:31]=[C:30]([C:32]([F:35])([F:34])[F:33])[CH:29]=[CH:28][N:27]=1.Br[C:37]1C=C(C(F)(F)F)C=CN=1>>[CH3:7][NH:5][C@H:4]([C:14]([NH:15][C@@H:16]1[C@@H:23]2[C@@H:19]([CH2:20][N:21]([C:26]3[N:31]=[C:30]([C:32]([F:35])([F:34])[F:33])[CH:29]=[CH:28][N:27]=3)[CH2:22]2)[CH2:18][CH2:17]1)=[O:24])[CH2:3][CH:2]([CH3:6])[CH3:37]참가 물질
실험 절차
The title compound was prepared by substituting tert-butyl methyl((S)-4-methyl-1-((3aR,4S,6aS)-octahydrocyclopenta[c]pyrrol-4-ylamino)-1-oxopentan-2-yl)carbamate from Example 619 Step 1 for (2S,4S)-tert-butyl 4-fluoro-2-((3aR,4S,6aS)-octahydrocyclopenta[c]pyrrol-4-ylcarbamoyl)pyrrolidine-1-carboxylate and 2-bromo-4-(trifluoromethyl)pyrimidine for 2-bromo-4-(trifluoromethyl)pyridine in the procedure described in Example 637: 1H NMR (400 MHz, pyridine-d5) δ ppm 8.49 (d, J=4.8, 1H), 7.75-7.64 (m, 1H), 6.74 (d, J=4.8, 1H), 4.29 (dt, J=14.2, 7.2, 1H), 3.83 (d, J=4.5, 1H), 3.75 (dd, J=11.9, 8.2, 1H), 3.46 (dd, J=11.9, 4.8, 1H), 3.17-3.09 (m, 1H), 2.83-2.65 (m, 2H), 2.38 (s, 3H), 2.19-2.09 (m, 1H), 2.01-1.89 (m, 1H), 1.84 (dq, J=13.1, 6.6, 1H), 1.73-1.60 (m, 2H), 1.56-1.37 (m, 2H), 0.93 (d, J=6.6, 3H), 0.89 (d, J=6.6, 3H); MS (ESI+) m/z 400 (M+H)+.
출처 및 근거
- ORD 기록
- ord-3f3314b832f34006845dc3c94f375a77
- 출처 데이터셋
- uspto-grants-2014_04
- 특허 번호
- US08691865B2
연결된 노트
불러오는 중…